Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Eurogentec S.A., part of Kaneka Corporation, is a leading global supplier of innovative products and services to the life science research, biotechnology, and diagnostic industries. They specialize in genomics (custom DNA/RNA oligonucleotides, PCR/qPCR kits, sequencing services), proteomics (custom peptides, antibodies), and biomanufacturing (cGMP production of recombinant proteins, plasmid DNA, and mRNA for therapeutic and vaccine applications). Eurogentec is committed to providing high-quality, reliable solutions to advance scientific discovery and improve healthcare outcomes.
The headquarters serves as the central hub for Eurogentec's global operations, including core research and development, cGMP manufacturing, sales, marketing, and administrative functions.
The facility includes state-of-the-art laboratories, cGMP-compliant manufacturing suites for biologics production, and advanced research equipment. It is designed to support high-quality, scalable production and innovative R&D.
The work culture at Eurogentec's headquarters emphasizes scientific excellence, innovation, collaboration, and a strong commitment to quality and customer satisfaction. Employees often come from diverse scientific backgrounds, fostering a dynamic and intellectually stimulating environment.
This location is significant as it's the historical base of the company and houses its primary manufacturing and R&D capabilities, enabling direct oversight of critical operations and product development. Its position in a science park fosters collaboration with other research institutions.
Eurogentec supports global life science research and biopharmaceutical production through its main manufacturing and R&D hub in Belgium, dedicated offices in North America (USA) and Japan, and a network of distributors covering Europe, Asia, the Middle East, and other regions. This network enables them to provide genomics, proteomics, and cGMP biomanufacturing services, along with technical support, to customers worldwide.
LIEGE Science Park, Rue du Bois Saint Jean 5
Seraing
Liège
Belgium
Address: 34800 Campus Drive, Fremont, CA 94555, USA (Eurogentec North America, Inc.)
To provide localized support and faster turnaround times for customers in North America, a key market for life sciences and biotechnology.
Address: c/o Kaneka Corporation, 2-3-18, Nakanoshima, Kita-ku, Osaka 530-8288, Japan (Kaneka Eurogentec Japan Business)
To expand Eurogentec's footprint in the Asian market, providing tailored solutions and support to researchers and biotech companies in the region.
Address: Information not readily available for a specific office, but France is a key market with sales representation.
To serve the significant French life science and biopharmaceutical research community.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Eurogentec' leadership includes:
Eurogentec has been backed by several prominent investors over the years, including:
No major publicly announced C-suite executive hires or exits specifically for Eurogentec S.A. have been prominently identified in the last 12 months. Leadership within the Kaneka group may have seen changes that indirectly affect Eurogentec. Continuous leadership evaluation is standard.
Discover the tools Eurogentec uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Eurogentec primarily uses the first initial followed by a period and then the last name for their email format.
f.lastname@eurogentec.com
Format
j.doe@eurogentec.com
Example
90%
Success rate
BioPharma Reporter • March 13, 2024
Kaneka Eurogentec has entered into a partnership with INEVO Technologies to combine their expertise for the development and optimization of mRNA manufacturing processes. This collaboration aims to enhance the efficiency and scalability of mRNA production for therapeutic applications....more
European Biotechnology • November 7, 2023
Kaneka Eurogentec announced plans to significantly expand its mRNA contract development and manufacturing organization (CDMO) capacity. This expansion includes new state-of-the-art facilities to meet the growing global demand for mRNA-based therapies and vaccines....more
GlobeNewswire (via Kaneka Eurogentec Press Release) • June 20, 2023
Kaneka Eurogentec's mRNA manufacturing facility in Belgium has received Good Manufacturing Practice (GMP) accreditation from Japan's Pharmaceuticals and Medical Devices Agency (PMDA). This accreditation allows the company to supply GMP-grade mRNA for clinical trials and commercial use in Japan....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Eurogentec, are just a search away.